Release Notes: Version 20190208
General Notes
The following files will be available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship,
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The 'Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release continues to add additional content from the DPD and includes most of the top 250 moieties and approximately 95% of the DPD content in scope for CCDD.
The table below provides the number of concepts within each CCDD file for this release.
February 2019 CCDD Files | Number of Concepts | Types of Changes in this release |
|---|---|---|
| Therapeutic Moiety Full Release | 1287 | 43 additions 3 formal name changes as described below (with no change to code) 1 status change from active to inactive 1 status change date change to an inactive concept |
| Non-proprietary Therapeutic Product Full Release | 3727 | 118 additions (113 for new TMs; 5 for existing TMs) 11 NTP formal name change as described below (with no change to code) 6 status change from active to inactive 25 status date changes with no change of status (including 14 concepts with a status of "Deprec") |
| Manufactured Product Full Release | 10348 | 212 additions
Formal name changes made:
49 status changes from active to inactive 6 status changes from inactive to active 14 status date changes (no change of status) |
Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Moiety Relationship | 10345 | Includes concept additions and changes as above Deprecated concepts have been excluded. |
| Device Non-proprietary Therapeutic Product | 3 | no change |
| Special Groupings | 1779 | 13 additional entries due to new concepts Includes concept additions and changes as above |
| Coded Attributes | 7 | no change |
Paragraphs Describing File Format
Additional information has been added to the "About the Technical Specification" page to describe the differences in the json and xml formats available on the Terminology Gateway.
Therapeutic Moiety (TM) Changes
The following TM concept was changed pursuant to a decision on naming of vitamin substances within CCDD which included the use of the vitamer name as the functional active ingredient in the TM:
tm_code February Release | tm_formal_name February Release | tm_code January Release | tm_formal_name January Release |
|---|---|---|---|
8000172 | cholecalciferol | 8000172 | vitamin D3 (cholecalciferol) |
8000413 | alendronic acid and cholecalciferol | 8000413 | alendronic acid and vitamin D3 (cholecalciferol) |
The following TM was changed to consistently represent the synonyms hyoscine and scopolamine in CCDD:
tm_code February Release | tm_formal_name February Release | tm_code January Release | tm_formal_name January Release |
8001482 | scopolamine butylbromide | 8001482 | hyoscine |
NTP Changes
The following NTP concepts were changed pursuant to a decision on naming of vitamin substances within CCDD which included the use of vitamer name as the precise active ingredient in the NTP formal name. The changes are as follows:
ntp_code February Release | ntp_formal_name February Release | ntp_code January Release | ntp_formal_name January Release |
|---|---|---|---|
9006480 | alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet | 9006480 | alendronic acid (alendronate sodium) 70 mg and vitamin D3 (cholecalciferol) 2800 unit oral tablet |
9006487 | alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet | 9006487 | alendronic acid (alendronate sodium) 70 mg and vitamin D3 (cholecalciferol) 5600 unit oral tablet |
9006496 | cholecalciferol 2000 unit oral capsule | 9006496 | vitamin D3 (cholecalciferol) 2000 unit oral capsule |
9006498 | cholecalciferol 5000 unit oral capsule | 9006498 | vitamin D3 (cholecalciferol) 5000 unit oral capsule |
9006479 | cholecalciferol 10000 unit oral capsule | 9006479 | vitamin D3 (cholecalciferol) 10000 unit oral capsule |
9006461 | cholecalciferol 10000 unit oral tablet | 9006461 | vitamin D3 (cholecalciferol) 10000 unit oral tablet |
9006497 | cholecalciferol 25000 unit oral capsule | 9006497 | vitamin D3 (cholecalciferol) 25000 unit oral capsule |
9006491 | cholecalciferol 50000 unit oral capsule | 9006491 | vitamin D3 (cholecalciferol) 50000 unit oral capsule |
The following NTPs were changed to consistently represent the synonyms hyoscine and scopolamine in CCDD:
ntp_code February Release | ntp_formal_name February Release | ntp_code January Release | ntp_formal_name January Release |
|---|---|---|---|
| 9012819 | scopolamine butylbromide 20 mg per 1 mL solution for injection vial | 9012819 | hyoscine butylbromide 20 mg per 1 mL solution for injection vial |
| 9001758 | scopolamine butylbromide 10 mg oral tablet | 9001758 | hyoscine butylbromide 10 mg oral tablet |
| 9012818 | scopolamine butylbromide 20 mg per 1 mL solution for injection ampoule | 9012818 | hyoscine butylbromide 20 mg per 1 mL solution for injection ampoule |
Manufactured Product (MP) Changes
The following Byetta products have had a change in DPD to remove the use of "µ" as follows:
| mp_code (Feb release) | mp_formal_name (Feb release) | mp_code (Jan release) | mp_formal_name (Jan release) |
| 02361817 | BYETTA (exenatide 10 mcg per actuation solution for injection pre-filled pen) ASTRAZENECA CANADA INC | 02361817 | BYETTA 2.4ML PREFILLED PEN. 60 DOSES OF 10µG/DOSE (exenatide 10 mcg per actuation solution for injection pre-filled pen) ASTRAZENECA CANADA INC |
| 02361809 | BYETTA (exenatide 5 mcg per actuation solution for injection pre-filled pen) ASTRAZENECA CANADA INC | 02361809 | BYETTA 1.2ML PREFILLED PEN. 60 DOSES OF 5µG/DOSE. (exenatide 5 mcg per actuation solution for injection pre-filled pen) ASTRAZENECA CANADA INC |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]
Please note that to access InfoCentral, you must have an Infoway login. If you have any questions about any of our standards or products, please contact the Infodesk Desk at:
Toll Free #: 1-877-595-3417 or 416-595-3417
E-mail: [email protected]